Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
5.26
-0.06 (-1.13%)
At close: Mar 13, 2026, 4:00 PM EDT
5.27
+0.01 (0.25%)
After-hours: Mar 13, 2026, 7:03 PM EDT
Protara Therapeutics Market Cap
Protara Therapeutics has a market cap or net worth of $284.48 million as of March 13, 2026. Its market cap has increased by 73.21% in one year.
Market Cap
284.48M
Enterprise Value
89.95M
1-Year Change
73.21%
Ranking
Category
Stock Price
$5.26
Market Cap Chart
Since January 10, 2020, Protara Therapeutics's market cap has increased from $173.16M to $284.48M, an increase of 64.29%. That is a compound annual growth rate of 8.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 284.48M | -0.40% |
| Dec 31, 2025 | 285.62M | 12.67% |
| Dec 31, 2024 | 253.49M | 1,089.52% |
| Dec 29, 2023 | 21.31M | -29.43% |
| Dec 30, 2022 | 30.20M | -60.18% |
| Dec 31, 2021 | 75.84M | -72.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Palisade Bio | 302.48M |
| Puma Biotechnology | 299.15M |
| AC Immune | 296.83M |
| Voyager Therapeutics | 290.25M |
| Nautilus Biotechnology | 289.83M |
| Foghorn Therapeutics | 288.81M |
| Context Therapeutics | 283.91M |
| Aldeyra Therapeutics | 281.05M |